tiprankstipranks
Valerio Therapeutics (GB:0NWK)
LSE:0NWK
UK Market
0NWK
Valerio Therapeutics
RESEARCH TOOLSreports
Want to see GB:0NWK full AI Analyst Report?

Valerio Therapeutics (0NWK) Ratios

1 Followers

Valerio Therapeutics Ratios

GB:0NWK's free cash flow for Q4 2025 was €1.47. For the 2025 fiscal year, GB:0NWK's free cash flow was decreased by € and operating cash flow was €-1.63. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Jun 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.76 0.76 0.25 1.17 2.88
Quick Ratio
 0.76 0.76 0.25 1.17 2.77
Cash Ratio
 0.17 0.17 0.06 0.61 2.04
Solvency Ratio
 0.00 0.00 -0.48 -0.91 -0.94
Operating Cash Flow Ratio
 0.29 0.29 -0.68 -1.67 -1.32
Short-Term Operating Cash Flow Coverage
 2.01 2.01 -1.71 -12.85 -9.41
Net Current Asset Value
€ -8.38M€ -8.38M€ -21.63M€ -7.47M€ -237.00K
Leverage Ratios
Debt-to-Assets Ratio
 0.50 0.50 0.75 0.26 0.23
Debt-to-Equity Ratio
 3.67 3.67 -1.50 0.61 0.45
Debt-to-Capital Ratio
 0.79 0.79 2.98 0.38 0.31
Long-Term Debt-to-Capital Ratio
 0.75 0.75 -1.71 0.32 0.27
Financial Leverage Ratio
 7.34 7.34 -2.01 2.38 1.93
Debt Service Coverage Ratio
 0.23 0.23 -1.63 -12.20 -5.41
Interest Coverage Ratio
 -1.96 -1.96 -52.68 -307.39 -7.79
Debt to Market Cap
 0.11 0.34 1.12 0.37 0.32
Interest Debt Per Share
 0.05 0.05 0.09 0.07 0.12
Net Debt to EBITDA
 12.09 12.09 -1.02 -0.12 0.26
Profitability Margins
Gross Profit Margin
67.08%67.08%71.39%70.39%64.38%
EBIT Margin
-169.30%-169.30%-1303.74%-1121.50%-1185.93%
EBITDA Margin
21.06%21.06%-672.73%-1024.67%-1180.67%
Operating Profit Margin
-21.38%-21.38%-919.63%-1127.11%-1186.07%
Pretax Profit Margin
-180.22%-180.22%-1313.61%-1129.28%-1335.62%
Net Profit Margin
-190.36%-190.36%-1334.69%-1130.22%-1355.65%
Continuous Operations Profit Margin
-190.36%-190.36%-1334.63%-1130.11%-1355.37%
Net Income Per EBT
105.63%105.63%101.60%100.08%101.50%
EBT Per EBIT
843.09%843.09%142.84%100.19%112.61%
Return on Assets (ROA)
-32.15%-32.15%-133.48%-57.67%-45.40%
Return on Equity (ROE)
139.11%-236.05%267.98%-137.41%-87.84%
Return on Capital Employed (ROCE)
-6.16%-6.16%4041.42%-84.03%-47.63%
Return on Invested Capital (ROIC)
-5.50%-5.50%-228.54%-78.26%-45.67%
Return on Tangible Assets
-69.35%-69.35%-401.46%-137.99%-87.51%
Earnings Yield
-17.69%-22.99%-207.36%-90.91%-68.51%
Efficiency Ratios
Receivables Turnover
 1.32 1.32 1.04 0.95 0.98
Payables Turnover
 0.37 0.37 0.10 0.22 0.15
Inventory Turnover
 0.00 0.00 0.00 88.83 0.69
Fixed Asset Turnover
 2.03 2.03 1.53 1.18 0.76
Asset Turnover
 0.17 0.17 0.10 0.05 0.03
Working Capital Turnover Ratio
 -0.33 -0.34 -0.30 0.24 0.08
Cash Conversion Cycle
 -707.34 -707.34 -3.38K -1.29K -1.55K
Days of Sales Outstanding
 276.48 276.48 352.58 384.26 374.11
Days of Inventory Outstanding
 0.00 0.00 0.00 4.11 528.33
Days of Payables Outstanding
 983.82 983.82 3.73K 1.68K 2.45K
Operating Cycle
 276.48 276.48 352.58 388.37 902.43
Cash Flow Ratios
Operating Cash Flow Per Share
 0.01 0.01 -0.08 -0.14 -0.09
Free Cash Flow Per Share
 <0.01 <0.01 -0.08 -0.14 -0.09
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.28 0.28 1.03 1.01 1.05
Dividend Paid and CapEx Coverage Ratio
 1.40 1.40 -39.06 -101.62 -19.35
Capital Expenditure Coverage Ratio
 1.40 1.40 -39.06 -101.62 -19.35
Operating Cash Flow Coverage Ratio
 0.24 0.24 -0.93 -2.07 -0.94
Operating Cash Flow to Sales Ratio
 0.71 0.71 -6.95 -10.33 -6.54
Free Cash Flow Yield
0.83%2.45%-110.73%-83.92%-34.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.65 -4.35 -0.48 -1.10 -1.46
Price-to-Sales (P/S) Ratio
 24.38 8.28 6.44 12.43 19.79
Price-to-Book (P/B) Ratio
 13.35 10.27 -1.29 1.51 1.28
Price-to-Free Cash Flow (P/FCF) Ratio
 120.40 40.89 -0.90 -1.19 -2.87
Price-to-Operating Cash Flow Ratio
 15.06 11.58 -0.93 -1.20 -3.02
Price-to-Earnings Growth (PEG) Ratio
 -0.04 0.05 -0.07 0.07 >-0.01
Price-to-Fair Value
 13.35 10.27 -1.29 1.51 1.28
Enterprise Value Multiple
 127.83 51.40 -1.97 -1.33 -1.41
Enterprise Value
 69.28M 27.86M 23.80M 24.56M 24.05M
EV to EBITDA
 127.83 51.40 -1.97 -1.33 -1.41
EV to Sales
 26.93 10.83 13.27 13.64 16.67
EV to Free Cash Flow
 132.98 53.47 -1.86 -1.31 -2.42
EV to Operating Cash Flow
 37.67 15.15 -1.91 -1.32 -2.55
Tangible Book Value Per Share
 -0.04 -0.04 -0.13 -0.04 0.01
Shareholders’ Equity Per Share
 0.01 0.01 -0.06 0.11 0.21
Tax and Other Ratios
Effective Tax Rate
 -0.06 -0.06 -0.02 >-0.01 -0.01
Revenue Per Share
 0.02 0.02 0.01 0.01 0.01
Net Income Per Share
 -0.03 -0.03 -0.16 -0.15 -0.18
Tax Burden
 1.06 1.06 1.02 1.00 1.01
Interest Burden
 1.06 1.06 1.01 1.01 1.13
Research & Development to Revenue
 0.22 0.22 2.87 5.38 7.66
SG&A to Revenue
 0.82 0.82 1.48 1.45 1.83
Stock-Based Compensation to Revenue
 0.03 0.03 0.22 0.29 0.50
Income Quality
 -0.38 -0.38 0.52 0.91 0.48
Currency in EUR